Percutaneous ethanol ablation of hepatocellular carcinoma: Periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment

AUTOR(ES)

Burton, Kirsteen Rennie

FONTE

Pulsus Group Inc

RESUMO

A novel case of acute pancreatitis in a patient treated with percutaneous ethanol injection (PEI) ablation for hepatocellular carcinoma is described. The most commonly reported adverse effects of PEI are hepatic or peritoneal hemorrhage, hepatic insufficiency or infarction. There are no previous reports of fatal acute pancreatitis as a result of conventional PEI.

Documentos Relacionados

• Hepatocellular carcinoma: development and early detection
• Screening for Hepatocellular Carcinoma: Review and Perspective
• Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
• Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
• Is the use of microwave ablation more effective and/or safe that radiofrequency ablation in the treatment of hepatocellular carcinoma?